No need to get panic about Darden...

Oh, there is too much competition. Why do we see so called red indicators in company's financials? Activist investor is demanding spinning off company's restaurants to better access share performance. All of these cause some discomfort to investors who like value investing. Restaurants like those from Darden Restaurants Inc (NYSE: DRI) who have been at the corner of our streets for longer time, are not certainly the growth candidates like Buffalo Wild Wings, Chipotle etc. Therefore, if they are growing slowly or there is no growth, it should not raise investors' eyes.

Restaurants industry faces one of the most fierce competition among other industries. It is significantly driven by consumer confidence, overall economy, weather, cost of raw food materials and diversification. Recently, NRN has released that months of September and October or overall Q4 of 2013 will be testing time for the industry because of US Government Shutdown and debt ceiling issues. Clearly, consumers are not ready to spend as much as they used to do when economy was in so called clear shape 2 months ago.

I have gone through DRI's financials, forecasts and ratios. I have created brief valuation model based on its dividends and free cash flow forecasts. And surprisingly, I have not found anything which makes me join the herd who is cautious about investing in DRI. Despite of 7% growth in revenues from 2012, operating margin squeezed by 12%. The most straight forward reasons behind this are increasing inflation in cost of raw goods and in labor rates. And that led to decrease in net income by 12% as well. ROE stands at 6.4% as compared to 8.3% in 2012.

But as I always believe, cash is the king. DRI has been able to generate $949m cash from operating activities in 2013 as compared to $762m in 2012 and $264m free cash flow to equity holders in 2013 as compared to $122m in 2012. Moreover, DRI has consistently increased distributing their earnings as dividends. It provides good source of income as part of total return. According to my model, at the end of trading day 10/11/2013, DRI's fundamental value based on dividend forecast should be $52.04-$54.89 and based on free cash flow to equity forecast should be $51.73-$56.30. In either case, it is above the closing price of 10/11/2013 which is $50.50.

Looking at my limited "working" experience in equity valuation, I may not provide insightful analysis. But since I use sensitivity analysis to derive fundamental price range, I can surely give my opinion for DRI as "Neutral-- Hold it" looking at the numbers.

$80 bil to $5bil... Painful (ouch!)

Source: Yahoo Finance

They pioneered the smartphone market. They made it ubiquitous. They nearly ruled it for a decade. They made people addicted to the phones. They sustained the barriers to entry for competitors for years... And as per ECON 101, barriers were supposed to be broken. Players were supposed to enter... They felt possible long-term threat. But they didn't innovate. They saw their market share shrinking slowly. But they didn't innovate. They saw continuous decline in market share and customer base. They thought about innovation. They considered their R&D lightly. They suffered. They launched something exceptional. And they realized it was too late. They, the pioneer of the booming smartphone market, started considering strategic alternatives yesterday. Who are they? They are Research in Motion, Waterloo, ON, Canada based company, who pioneered BlackBerry, aka Crackberry (This name has nothing to do with their demise, but it was given when BlackBerry was the only smartphone option).

When I was young, I always wanted to own BlackBerry. And that's why I had BlackBerry as my first smartphone in mid 2009. Since then, I have had BlackBerry only. Currently, I am using BlackBerry Z10, runs on BB's new OS, BB10. I neither own any BBRY stock nor sit on their Board. I just want to writ what I feel. These should be enough disclosures for any conflict of interests!

BB 10, is by far the best RIMM has developed. I will not use word "innovate", because it may attract some critics. Apple's iPhones and Google's Android devices have become so "generic" these days, which is the prime factor for BBRY's dwindling customer base. The way BB 10 works, consider fast & smooth, if it was launched 2 years ago, the results could have been different. Only, the only, problem it has, is lack of apps. They have lost developers' interests as well along with customers. Recently, they announced to offer BBM, their premier messaging service, to other platforms. I am not really sure how useful it can be. But one thing I am absolutely sure about is BB 10 is all they can offer. There is nothing beyond that.

I have no vision for their future. They may be out of the business in 2015 when I will be hunting for a new phone. There is a huge possibility that I will not be able to get BBRY phone in the market in 2015. But I strongly believe that I will have good solid time with current Z 10 I have until 2015.

From one corner of my heart, I thank Apple and Google for bringing smartphone market to this level in such a short span. And that is the premier reason why BlackBerry developed their best product. And I could get a chance to use that!

Novo Nordisk Roars Again...

Novo Nordisk A/S, NYSE: NVO, a Denmark based global pharma giant, has been one of my top healthcare picks since long time. Why? Simple reasons:

• Impressive & deep pipeline
• Pipeline primarily focused on Diabetes, a chronic disease which has been delivering global burden to healthcare. According to International Diabetes Federation, approximately 552 million people in world will have diabetes. 
• Sustainable equity and cash flow growth

Source: Yahoo Finance

At the end of Q2 2013, NVO announced better outlook for the rest of 2013 as compared to their announcement of outlook on May 1. Booming sales of Victoza, Modern Insulins and their other long standing diabetes products have given them a great position in this disease sector. And they will continue to do that as per analysts' expectations.

Illegal Insider Trading

Wire tapes... SEC... FBI...Whistle blowing?... Arrest... Plead guilty?... And what not?... Bottom line is Illegal Insider Trading- A tagline which we have been hearing about for past 2-3 years. Why does it happen on the first place? And if that happens, why does it come to public after years? I guess it is a part of a vicious cycle. And this does not mean I favor some/rare insider trading. It must not happen at all to preserve the integrity of financial markets which drive the globe in all ways.

When economy is booming, everyone tries make more money to save their jobs and their company position. No one bothers to investigate why he or she or they are making insane amount of money. But when everything cools down and if that cooling down turns in to a recession or freezing of liquidity, authorities wonder why these have happened. And they start investigation, they find culprits. All get warned. Temporary freeze in insider trading. And again, when economy picks up, competition to make money and to chase big traders/ banks begins ("Chasing Goldman Sachs" book depicts how traders/ hedge funds want to make money so badly that they forget ethics... Why? Just to combat the competition. If trading platform of ABC bank makes this much, why can't we do that?).

This must stop or extra efforts must be provided to prevent it. Whole world runs on financial markets. If it does not save its integrity, everything becomes vulnerable to shatter.

Flying and Soaring Watson Pharmaceuticals

I estimated and you beat it. That is what Watson Pharmaceuticals (NYSE: WPI) has done to me! WPI has always been my favorite healthcare pick alongside Novo Nordisk for a year. Strong fundamentals, eye-catching financials, robust pipeline and stupendous expansion- this is what WPI stands for to me. Today Watson released their 2Q 2012 earnings and they beat all estimates. Whether you give credit to generic Lipitor(r) or to generic Lovenox(r) or any of the above qualities I mentioned, Watson has been delivering.

Watson is one of the biggest and fastest growing generics manufacturing company in the world. As per above figure, its global brands business complements its rapidly expanding global generics and anda distribution businesses. 2Q 2012 results do not reflect the effects of recently passed Healthcare Reform Bill which provides rosy outlook for generics. Moreover, it does not reflect the recent acquisition of Actavis. If WPI gains the expected synergy from Actavis acquisition during 4Q 2012, it will prepare WPI to set 2012 annual revenues to beat the street estimates.

When I ran the valuation model few months ago, I got the price target of approximately $73. And WPI is above that right now. It was and it is a "strong buy" to me.

Business Cycle Transparency

Developed economies are more transparent than emerging economies are. We all have heard about this, haven't we? If that is the fact, then I need to make myself work harder to believe it.

After the great recession hit the world in the year 2008, I could never understand clearly in what phase of the business cycle the US was and has been. Is it early upswing or late upswing or is it slowdown? Only thing I am sure about is that it is certainly neither initial recovery nor recession (please correct me if I am wrong). Recent healthy economic growth and relatively low inflation in the US suggests that we are in early upswing. There are no restrictive policies in the place as of now and that does not put us in the late upswing phase. But nervous investors have begun to think that equities are volatile and stock market is near its all-time peak in the 2007. Isn't that favoring late upswing? It is dilemma to me since I am not an economist! Capital market expectations are always critical to judge after prolonged recessions and a depression. If we observe emerging economies, they are believed to bounce back from shocks faster than developed nations do. This was true even after the great recession. For example, India is clearly in late upswing phase where it is feeling tremendous inflationary pressure. Equity markets in India have shown considerable volatility. Monetary policies have become restrictive and short rates are rising to curb boom mentality. India is showing business cycle transparency which I want to observe here in the US. But I may be asking too much from $14 trillion economy. Perhaps that transparency has partly been offset by the great recession.

As I heard and expected, Apple has delivered finally...

$40, $50, $60, $70, $80, $90, $100 billion and counting. This is how the world's most valuable company has increased its cash over the last 3 years. Whenever companies sit on huge cash piles, there are always 2 possibilities. First, companies become conservative, especially post-recession years, in capital investments and hiring, and reports plethora of cash to combat another economic stress. Second, companies face controversial times from the investors. We strongly believe that Apple falls in to second choice.

When do companies pay dividends and when do they repurchase shares? Simple answers and simple signals. When a company believes that there are no more opportunities to invest money, acquire assets or there is a shrinking room for current above average growth, they pay dividends to reward investors. And when a company believes that their equity is undervalued, they repurchase some shares in the market. I have not performed any equity fundamentals on $AAPL and this is why I cannot say if its equity market value is undervalued or overvalued. But I can somehow convince myself that there is some decrease in growth is forecast by the management after a dream post-recession run and paying dividends is the best way to keep investors tagged along.

As I heard and expected over the last few months, Apple has finally announced to pay dividends and $10 billion worth of share repurchase today. Though its dividend yield is less than its peers, it is going to be interesting new chapter for Apple, being considered mature in the market.